Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Patients with hematologic malignancies (HM) have demonstrated impaired immune responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity remain largely undetermined. A literature search was conducted using PubMed, EMBASE, Cochrane, and medRxiv databases to identify studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Uaprasert, Noppacharn, Pitakkitnukun, Palada, Tangcheewinsirikul, Nuanrat, Chiasakul, Thita, Rojnuckarin, Ponlapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780106/
https://www.ncbi.nlm.nih.gov/pubmed/36550105
http://dx.doi.org/10.1038/s41408-022-00776-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780106/
https://www.ncbi.nlm.nih.gov/pubmed/36550105
http://dx.doi.org/10.1038/s41408-022-00776-5

Ejemplares similares